Artificial Organs Market Size to Surpass USD 44.5 Billion by 2033, Rising At A CAGR Of 7.22%

𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐎𝐫𝐠𝐚𝐧𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲: 𝐊𝐞𝐲 𝐒𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬 𝐚𝐧𝐝 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧 𝟐𝟎𝟐𝟓-𝟐𝟎𝟑𝟑

𝐒𝐮𝐦𝐦𝐚𝐫𝐲:

● The global artificial organs market size reached USD 22.2 Billion in 2024.
● The market is expected to reach USD 44.5 Billion by 2033, exhibiting a growth rate (CAGR) of 7.22% during 2025-2033.
● North America leads the market, accounting for the largest artificial organs market share.
● Artificial kidney dominates the artificial organs industry.
● The growing incidence of organ failure and chronic diseases among the masses is a primary driver of the artificial organs market.
● Technological advancements and rising awareness and education efforts are reshaping the artificial organs market.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭: https://www.imarcgroup.com/artificial-organs-market/requestsample

𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

● 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐢𝐧𝐜𝐢𝐝𝐞𝐧𝐜𝐞 𝐨𝐟 𝐨𝐫𝐠𝐚𝐧 𝐟𝐚𝐢𝐥𝐮𝐫𝐞 𝐚𝐧𝐝 𝐜𝐡𝐫𝐨𝐧𝐢𝐜 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬:

An increase in people suffering from organ failures which they mainly attribute to ageing and increasing incidence of chronic diseases is a major driver to the market. Comorbidities include renal disease, liver cirrhosis, heart failure, and lung diseases, and millions of patients worldwide need an effective treatment. Donor organs are still in high demand but the supply is very low, there is always a long queue and a limited availability of compatible Donor organs. Artificial organs remain a viable option for patients who in any other way would deteriorate or die. Furthermore, technological advancements mean that there is enhanced availability of a canopy of health-care and as healthcare infrastructure progresses especially in the emergent markets the artificial organs are also being produced in a manner that can reach out to a increased base of patients. This increasing need combined with the improvement in the access to such technological solutions is pressuring healthcare providers and policymakers to back new artificial organ development.

● 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐬:

Advancements in the field of bioengineering are only making it possible to develop superior performing and durable technologies. Advances in material engineering prominent in the field of biocompatibility polymers and bioresorbable materials are leading to artificial organs to blend more perfect with human cells, and the rejection rates are decreasing considerably to offer superior result to patients. In addition, growth in 3D Printing technology will enhance the manufacture of artificial body organs fit to the specific body structure of patients. During the design and test phases, advances in AI/ML technology are also making it possible to model design requirements more accurately and create better-safe and better-reliable products. They are making artificial organs safer and more efficient, as such making them more acceptable withing the health care facilities and by patients.

● 𝐑𝐢𝐬𝐢𝐧𝐠 𝐚𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐚𝐧𝐝 𝐞𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧 𝐞𝐟𝐟𝐨𝐫𝐭𝐬:

Consumer acceptance and perception benefiting from awareness campaigns and educational programs seem to be driving the increased acceptance of artificial organs. In the past, lack of knowledge or knowledge in its misinformation form worked as a hindrance to the use of artificial body parts. But on their own, the governments, healthcare providers, and advocacy groups are making efforts informing the existing and potential beneficiaries about the effectiveness and safety of artificial organs. They focus on the positive outcomes of the process for people who received artificial organs, thus showing how often encountered objections will not stop people from receiving an artificial organ they need. Increased consciousness among individuals concerned as well as among potential recipients is ultimately resulting in better decision to receive the artificial organs with intention of leading better and healthier lives.

𝐀𝐬𝐤 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.imarcgroup.com/request?type=report&id=833&flag=C

𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐎𝐫𝐠𝐚𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐁𝐲 𝐓𝐲𝐩𝐞:

● Artificial Kidney
● Artificial Heart
● Artificial Pancreas
● Cochlear Implants
● Others

Artificial kidney exhibits a clear dominance in the market due to the high prevalence of kidney-related diseases and the critical demand for dialysis alternatives.

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧:

● North America (United States, Canada)
● Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
● Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
● Latin America (Brazil, Mexico, Others)
● Middle East and Africa

North America dominates the market owing to advanced healthcare infrastructure, rising research and development (R&D) investments, and higher adoption of artificial organ technology.

𝐓𝐨𝐩 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐎𝐫𝐠𝐚𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐋𝐞𝐚𝐝𝐞𝐫𝐬:

The artificial organs market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

● Abiomed, Inc.
● HeartWare International, Inc.
● Edwards Lifesciences Corp
● Boston Scientific Corporation
● Cochlear Limited

𝐈𝐟 𝐲𝐨𝐮 𝐫𝐞𝐪𝐮𝐢𝐫𝐞 𝐚𝐧𝐲 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐭𝐡𝐚𝐭 𝐢𝐬 𝐧𝐨𝐭 𝐜𝐨𝐯𝐞𝐫𝐞𝐝 𝐜𝐮𝐫𝐫𝐞𝐧𝐭𝐥𝐲 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐞 𝐬𝐜𝐨𝐩𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭, 𝐰𝐞 𝐰𝐢𝐥𝐥 𝐩𝐫𝐨𝐯𝐢𝐝𝐞 𝐭𝐡𝐞 𝐬𝐚𝐦𝐞 𝐚𝐬 𝐚 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

This release was published on openPR.